IQSEC2 and epilepsy: The condition is likely to be underdiagnosed when the current prevalence figures are compared to the observed frequency of IQSEC2 pathogenic variants in 2% of all patients with ID and epilepsy who underwent a whole exome sequencing analysis [15].